Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Department of Health and Human Services (NIH)
No specified budget limits; maximum project period of 5 years.
To support translational and clinical research to advance precision medicine in pregnant women, lactating women, and children.
Pregnant women, lactating women, fetuses, neonates, children, including those with disabilities.
Reissue of PAR-23-130; aligns with agency priorities.
NIH funding; Research Project Grant (R01).
Addresses unmet needs for safe and effective therapies for maternal and pediatric populations.
Recurring funding opportunity.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Federal Governments
U.S. Territory or Possession
Other (e.g., Independent School Districts, Public Housing Authorities)
Must have an eRA Commons account for Program Directors/Principal Investigators.
Open to U.S. and foreign organizations.
Not specified.
Translational and clinical research in maternal and pediatric pharmacology.
Improved safe and effective precision therapeutics for targeted populations.
Research expertise in maternal and pediatric pharmacology.
Application budgets are not limited but must reflect actual project needs.
Next application deadline is June 5, 2025.
Must comply with NIH Grants Policy Statement.
Follow instructions in the How to Apply - Application Guide.